Q: Pat: BioLineRx is an Israeli company working in several health areas. It seems that one or more of its initiatives will succeed (of course none might). Do you have an opinion on BioLineRX? Thanks and best wishes.

A: BioLineRx (ADR), $1.18, symbol BLRX on Nasdaq (ADRs outstanding: 59.1 million; Market cap: $69.7 million; www.biolinerx.com), is a clinical-stage biopharmaceutical company that aims to identify, license and develop promising therapeutic medications and treatments. It’s based in Israel.
The company licenses the new drug compounds of… Read More

Growth Stocks: Cemex benefits from booming construction

Growth Stocks: Cemex benefits from booming construction

Pat McKeough recently replied to an Inner Circle member looking for an opinion on this leading cement producer. The stock has jumped on rising construction, says Pat. But it still faces challenges. 
Q: Hi Pat: Could you comment on Cemex please and let me know if… Read More

Nissan sells key asset

NISSAN MOTOR (ADR) $18.77 (Nasdaq symbol NSANY; TSINetwork Rating: Above Average) (310-771-3111; www.nissan-global.com; ADRs outstanding 2.1 billion; Market cap: $40.3 billion; Dividend yield: 3.1%) plans to sell its interest in auto parts maker Calsonic Kansei to U.S. investment firm Kohlberg Kravis Roberts (KKR).
Calsonic Kansei is… Read More

Here are the top ETFs for precious metals

Here are the top ETFs for precious metals

These two ETFs offer low-fee exposure to the world’s top gold and silver mining stocks.

In 2011, gold shot up to a high of $1,950 U.S. an ounce, and silver reached a peak of $48.48.

Gold prices then fell steadily, dropping to $1,050 an ounce in December… Read More

Best ETFs for gold and silver exposure

In 2011, gold shot up to a high of $1,950 U.S. an ounce, and silver reached a peak of $48.48.
Gold prices then fell steadily, dropping to $1,050 an ounce in December 2015 for the first time since early 2010. That month, silver also declined to… Read More